Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Olive

Showing results (121-130 of 276) with videos related to

Pageof 28
Sort By:
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Blood|January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemiaMohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
International Immunology|October 23, 2012
PD-1 is a novel regulator of human B-cell activationMarie-Laure Thibult, Emilie Mamessier, Julie Gertner-Dardenne, et al.
Frontiers in Immunology|July 14, 2022
BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against <i>Coxiella burnetii</i>-Infected CellsLaetitia Gay, Soraya Mezouar, Carla Cano, et al.
European Journal of Immunology|June 23, 2011
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatmentFederica Bozzano, Antonino Picciotto, Paola Costa, et al.
Plos One|September 12, 2014
Imbalance of circulating monocyte subsets and PD-1 dysregulation in Q fever endocarditis: the role of IL-10 in PD-1 modulationMignane B Ka, Françoise Gondois-Rey, Christian Capo, et al.
Immunology|June 23, 2015
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cellsMarta Siernicka, Magdalena Winiarska, Malgorzata Bajor, et al.
Cancer Research|May 16, 2015
Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 AntibodiesSandra Heskamp, Willemijn Hobo, Janneke D M Molkenboer-Kuenen, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2012
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cellsMarie-Laure Thibult, Jean-Paul Rivals, Emilie Mamessier, et al.
Blood|May 23, 2013
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cellsJulie Gertner-Dardenne, Cyril Fauriat, Florence Orlanducci, et al.
Pageof 28

Showing results (121-130 of 276) with videos related to

Sort By:
Pageof 28
The Journal of Biological Chemistry|August 1, 2012
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodiesAparna Palakodeti, Andrew Sandstrom, Lakshmi Sundaresan, et al.
Blood|January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemiaMohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
International Immunology|October 23, 2012
PD-1 is a novel regulator of human B-cell activationMarie-Laure Thibult, Emilie Mamessier, Julie Gertner-Dardenne, et al.
Frontiers in Immunology|July 14, 2022
BTN3A Targeting Vγ9Vδ2 T Cells Antimicrobial Activity Against <i>Coxiella burnetii</i>-Infected CellsLaetitia Gay, Soraya Mezouar, Carla Cano, et al.
European Journal of Immunology|June 23, 2011
Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatmentFederica Bozzano, Antonino Picciotto, Paola Costa, et al.
Plos One|September 12, 2014
Imbalance of circulating monocyte subsets and PD-1 dysregulation in Q fever endocarditis: the role of IL-10 in PD-1 modulationMignane B Ka, Françoise Gondois-Rey, Christian Capo, et al.
Immunology|June 23, 2015
Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cellsMarta Siernicka, Magdalena Winiarska, Malgorzata Bajor, et al.
Cancer Research|May 16, 2015
Noninvasive Imaging of Tumor PD-L1 Expression Using Radiolabeled Anti-PD-L1 AntibodiesSandra Heskamp, Willemijn Hobo, Janneke D M Molkenboer-Kuenen, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 21, 2012
CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cellsMarie-Laure Thibult, Jean-Paul Rivals, Emilie Mamessier, et al.
Blood|May 23, 2013
The co-receptor BTLA negatively regulates human Vγ9Vδ2 T-cell proliferation: a potential way of immune escape for lymphoma cellsJulie Gertner-Dardenne, Cyril Fauriat, Florence Orlanducci, et al.
Pageof 28